ANDEMBRY
Garadacimab
Listed by CSL
- Strength
- 200 mg/1.2mL
- Form
- Injection, Solution
- Route
- Subcutaneous
What it contains
- Garadacimab 200 mg/1.2mL
FDA record
| Dosage form | Injection, Solution |
|---|---|
| Route | Subcutaneous |
| Approval route | BLA — biologic licence |
| NDC code | 63833-925 |
| FDA application | BLA761367 |
| RxNorm concept | 2717175 |
| Package sizes listed | 1 |
| Marketed since | June 2025 |
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.